These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

94 related items for PubMed ID: 10727064

  • 1. Hepatic osteodystrophy in elderly: role of insulin-like growth factor-I and osteocalcin.
    Cotrozzi G, Giusti S, Bini S, Carloni V, Mazzocca A, Frati M.
    J Endocrinol Invest; 1999; 22(10 Suppl):88-9. PubMed ID: 10727064
    [No Abstract] [Full Text] [Related]

  • 2. [Endocrine-metabolic aspects of rarefying osteopathy of patients with cirrhosis].
    Grandi M, Pederzoli S, Sacchetti C, Maietta A, Bonati ME, Riva P.
    Recenti Prog Med; 1991; 82(7-8):363-6. PubMed ID: 1947398
    [Abstract] [Full Text] [Related]

  • 3. [Hepatic osteodystrophy in our environment].
    Suárez Jiménez MI, Vergara de Campos A, Rico Irles J.
    Rev Clin Esp; 1985 Mar; 176(4):177-81. PubMed ID: 4001466
    [No Abstract] [Full Text] [Related]

  • 4. The use of vitamin K may be a good choice for microgravity-induced bone disorder.
    Sugiyama T, Kawai S.
    J Bone Miner Res; 2001 Apr; 16(4):794-5. PubMed ID: 11316009
    [No Abstract] [Full Text] [Related]

  • 5. Serum insulin/like growth factor I, bone mineral density and biochemical markers of bone metabolism in children with idiopathic osteoporosis.
    Chlebna-Sokol D, Rusinska A.
    Endocr Regul; 2001 Dec; 35(4):201-8. PubMed ID: 11858767
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. [Organic nephropathies in patients with liver diseases].
    Amoedo ML, Montoliu J.
    Gastroenterol Hepatol; 1996 Mar; 19(3):167-77. PubMed ID: 8991663
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Clinical uses of insulin-like growth factor I.
    Hussain MA, Froesch ER.
    Adv Endocrinol Metab; 1995 Mar; 6():143-65. PubMed ID: 7671094
    [No Abstract] [Full Text] [Related]

  • 10. Serum insulin-like growth factor I evaluation as a useful tool for predicting the risk of developing hepatocellular carcinoma in patients with hepatitis C virus-related cirrhosis: a prospective study.
    Mazziotti G, Sorvillo F, Morisco F, Carbone A, Rotondi M, Stornaiuolo G, Precone DF, Cioffi M, Gaeta GB, Caporaso N, Carella C.
    Cancer; 2002 Dec 15; 95(12):2539-45. PubMed ID: 12467068
    [Abstract] [Full Text] [Related]

  • 11. Oval cells in hepatitis B virus-positive and hepatitis C virus-positive liver cirrhosis: histological and ultrastructural study.
    Sun C, Jin XL, Xiao JC.
    Histopathology; 2006 Apr 15; 48(5):546-55. PubMed ID: 16623780
    [Abstract] [Full Text] [Related]

  • 12. Clinical benefits of biochemical markers of bone turnover in Egyptian children with chronic liver diseases.
    Mahdy KA, Ahmed HH, Mannaa F, Abdel-Shaheed A.
    World J Gastroenterol; 2007 Feb 07; 13(5):785-90. PubMed ID: 17278204
    [Abstract] [Full Text] [Related]

  • 13. Hepatic osteodystrophy. Static and dynamic bone histomorphometry and serum bone Gla-protein in 80 patients with chronic liver disease.
    Diamond TH, Stiel D, Lunzer M, McDowall D, Eckstein RP, Posen S.
    Gastroenterology; 1989 Jan 07; 96(1):213-21. PubMed ID: 2783312
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Osteoblast dysfunction in male idiopathic osteoporosis.
    Pernow Y, Granberg B, Sääf M, Weidenhielm L.
    Calcif Tissue Int; 2006 Feb 07; 78(2):90-7. PubMed ID: 16467976
    [Abstract] [Full Text] [Related]

  • 16. Osteopenia and osteoporosis in patients with end-stage liver disease caused by hepatitis C and alcoholic liver disease: not just a cholestatic problem.
    Carey EJ, Balan V, Kremers WK, Hay JE.
    Liver Transpl; 2003 Nov 07; 9(11):1166-73. PubMed ID: 14586877
    [Abstract] [Full Text] [Related]

  • 17. [Hepato-biliary and pancreatic disease and osteodystrophy].
    Imaeda K, Nojiri S.
    Clin Calcium; 2009 Sep 07; 19(9):1275-80. PubMed ID: 19721198
    [Abstract] [Full Text] [Related]

  • 18. [Vascular purpura in patients with chronic diffuse hepatic diseases].
    Russkikh AV, Kozlovskaia LV, Krivosheev OG, Mukhin NA.
    Klin Med (Mosk); 2005 Sep 07; 83(10):45-8. PubMed ID: 16320846
    [Abstract] [Full Text] [Related]

  • 19. Biliary intraepithelial neoplasia in patients without chronic biliary disease: analysis of liver explants with alcoholic cirrhosis, hepatitis C infection, and noncirrhotic liver diseases.
    Wu TT, Levy M, Correa AM, Rosen CB, Abraham SC.
    Cancer; 2009 Oct 01; 115(19):4564-75. PubMed ID: 19670455
    [Abstract] [Full Text] [Related]

  • 20. [Growth factors in assessing hepatic fibrosis in patients with chronic hepatitis C].
    Ivkova AN, Il'chenko LIu, Kushlinskiĭ NE, Petrenko NV, Storozhakov GI.
    Eksp Klin Gastroenterol; 2008 Oct 01; (5):42-6. PubMed ID: 19145916
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 5.